Sr One Capital Management as of March 31, 2026
Portfolio Holdings for Sr One Capital Management
Sr One Capital Management holds 14 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arcellx Common Stock (ACLX) | 29.4 | $269M | 2.3M | 114.82 | |
| Veradermics Common Stock (MANE) | 16.6 | $152M | 2.4M | 63.15 | |
| Zenas BioPharma Common Stock (ZBIO) | 10.8 | $99M | 5.0M | 19.55 | |
| CRISPR Therapeutics Common Shares (CRSP) | 10.6 | $97M | 2.0M | 47.57 | |
| Design Therapeutics Common Stock (DSGN) | 7.6 | $69M | 6.5M | 10.64 | |
| ORIC Pharmaceuticals Common Stock (ORIC) | 6.4 | $59M | 4.5M | 12.95 | |
| Alumis Common Stock (ALMS) | 4.7 | $43M | 2.0M | 22.03 | |
| Mineralys Therapeutics Common Stock (MLYS) | 4.6 | $42M | 1.6M | 27.09 | |
| ARS Pharmaceuticals Common Stock (SPRY) | 3.5 | $32M | 4.0M | 8.03 | |
| Oruka Therapeutics Common Stock (ORKA) | 2.3 | $21M | 430k | 49.05 | |
| Oculis Holding Ordinary Shares (OCS) | 1.9 | $17M | 641k | 26.59 | |
| Nkarta Common Stock (NKTX) | 0.8 | $7.0M | 3.3M | 2.11 | |
| enGene Holdings Common Shares | 0.6 | $5.1M | 748k | 6.81 | |
| Ultragenyx Pharmaceutical Common Stock (RARE) | 0.3 | $2.9M | 138k | 20.95 |
